Safety of Recombinant VSV-Ebola Virus Vaccine Vector in Pigs

被引：25
|
作者：
de Wit, Emmie [1 ]
Marzi, Andrea [1 ]
Bushmaker, Trenton [1 ]
Brining, Doug [1 ]
Scott, Dana [1 ]
Richt, Juergen A. [2 ]
Geisbert, Thomas W. [3 ]
Feldmann, Heinz [1 ,4 ]
机构：
[1] NIAID, Hamilton, MT 59840 USA
[2] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA
[3] Univ Texas Med Branch, Galveston, TX 77555 USA
[4] Univ Manitoba, Winnipeg, MB, Canada
来源：
EMERGING INFECTIOUS DISEASES | 2015年 / 21卷 / 04期
基金：
美国国家卫生研究院;
关键词：
VESICULAR STOMATITIS-VIRUS; NONHUMAN-PRIMATES; GLYCOPROTEINS;
D O I：
10.3201/eid2104.142012
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The ongoing Ebola outbreak in West Africa has resulted in fast-track development of vaccine candidates. We tested a vesicular stomatitis virus vector expressing Ebola virus glycoprotein for safety in pigs. Inoculation did not cause disease and vaccine virus shedding was minimal, which indicated that the vaccine virus does not pose a risk of dissemination in pigs.
引用
收藏
页码：702 / 704
页数：3
相关论文
共 50 条
  • [1] Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
    Poetsch, Joseph H.
    Dahlke, Christine
    Zinser, Madeleine E.
    Kasonta, Rahel
    Lunemann, Sebastian
    Rechtien, Anne
    Ly, My L.
    Stubbe, Hans C.
    Kraehling, Verena
    Biedenkopf, Nadine
    Eickmann, Markus
    Fehling, Sarah K.
    Olearo, Flaminia
    Strecker, Thomas
    Sharma, Piyush
    Lang, Karl S.
    Lohse, Ansgar W.
    Schmiedel, Stefan
    Becker, Stephan
    Siegrist, Claire-Anne
    Huttner, Angela
    Addo, Marylyn M.
    Bejon, Phillip
    Njuguna, Patricia
    Ndungu, Francis
    Kremsner, Peter G.
    Brosnahan, Jessica S.
    Agnandji, Selidji Todagbe
    Krishna, Sanjeev
    Kieny, Marie Paule
    Modjarrad, Kayvon
    Moorthy, Vasee
    Fast, Patricia
    Savarese, Barbara
    Lapujade, Olivier
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (04): : 556 - 561
  • [2] Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine
    Grobusch, Martin P.
    Goorhuis, Abraham
    LANCET, 2017, 389 (10069): : 578 - 580
  • [3] VSV-GP: A vaccine vector and oncolytic virus
    Muik, Alexander
    Kimpel, Janine
    Tober, Reinhard
    Urbiola, Carles
    von Laer, Dorothee
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [4] Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies
    Khurana, Surender
    Fuentes, Sandra
    Coyle, Elizabeth M.
    Ravichandran, Supriya
    Davey, Richard T., Jr.
    Beigel, John H.
    NATURE MEDICINE, 2016, 22 (12) : 1439 - +
  • [5] A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
    Regules, J. A.
    Beigel, J. H.
    Paolino, K. M.
    Voell, J.
    Castellano, A. R.
    Hu, Z.
    Munoz, P.
    Moon, J. E.
    Ruck, R. C.
    Bennett, J. W.
    Twomey, P. S.
    Gutierrez, R. L.
    Remich, S. A.
    Hack, H. R.
    Wisniewski, M. L.
    Josleyn, M. D.
    Kwilas, S. A.
    Van Deusen, N.
    Mbaya, O. T.
    Zhou, Y.
    Stanley, D. A.
    Jing, W.
    Smith, K. S.
    Shi, M.
    Ledgerwood, J. E.
    Graham, B. S.
    Sullivan, N. J.
    Jagodzinski, L. L.
    Peel, S. A.
    Alimonti, J. B.
    Hooper, J. W.
    Silvera, P. M.
    Martin, B. K.
    Monath, T. P.
    Ramsey, W. J.
    Link, C. J.
    Lane, H. C.
    Michael, N. L.
    Davey, R. T., Jr.
    Thomas, S. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04): : 330 - 341
  • [6] Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies
    Surender Khurana
    Sandra Fuentes
    Elizabeth M Coyle
    Supriya Ravichandran
    Richard T Davey
    John H Beigel
    Nature Medicine, 2016, 22 : 1439 - 1447
  • [7] Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV
    Velazquez-Salinas, Lauro
    Naik, Shruthi
    Pauszek, Steven J.
    Peng, Kah-Whye
    Russell, Stephen J.
    Rodriguez, Luis L.
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2017, 28 (02) : 108 - 115
  • [8] Ebola virus vaccine safety in frontline workers
    Reactions Weekly, 2018, 1723 (1) : 9 - 9
  • [9] Correction: Corrigendum: Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies
    Surender Khurana
    Sandra Fuentes
    Elizabeth M Coyle
    Supriya Ravichandran
    Richard T Davey
    John H Beigel
    Nature Medicine, 2017, 23 : 264 - 264
  • [10] Safety of inoculation of bovine parainfluenza virus 3 as potential vaccine vector in pigs
    Wang F.-X.
    Liu Y.
    Zhu H.-W.
    Liu X.
    Yang Y.
    Sun N.
    Cheng S.-P.
    Wen Y.-J.
    VirusDisease, 2015, 26 (1-2) : 89 - 91
12345